Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab
Authors
Keywords
Melanoma, Adverse event, Checkpoint inhibitor, White blood cell count, Blood cell parameters, Relative lymphocyte count
Journal
JOURNAL OF DERMATOLOGICAL SCIENCE
Volume 88, Issue 2, Pages 225-231
Publisher
Elsevier BV
Online
2017-07-16
DOI
10.1016/j.jdermsci.2017.07.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.